2m 2m 2m 2m 2m 2m 2m
ONCOLYTICS (ONCY)
NASDAQ
$0.95+$0.01 (+1.07%)
Price as of Jun 23, 2026 7:55 PM EDT- $109.5MMarket Cap
- 39.62%1-Year Change
- BiotechnologyIndustry
ONCOLYTICS (ONCY)
$0.95+$0.01 (+1.07%)
ONCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.94 | ||
Change | +$0.02 (+2.58%) | ||
Open | $0.91 | ||
High | $0.98 | ||
Low | $0.91 | ||
Previous Close | $0.92 | ||
Volume | 977,243 | ||
30-Day Average Volume | 1,808,734 | ||
1-Week Change | -0.91% | ||
1-Month Change | 16.23% | ||
1-Year Change | 39.62% | ||
3-Year Change | -65.66% | ||
5-Year Change | -67.33% | ||
Fundamentals | |||
Shares Outstanding | 119.4M | ||
Total Assets | $8.2M | ||
Market Cap | $109.5M | ||
Enterprise Value | $104.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.2M | ||
Free Cash Flow | -$7.3M | ||
EBIT | -$9.2M | ||
EBITDA | -$9.2M | ||
Net Working Capital | N/A | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -21 | ||
P/E | -11 | ||
PEG | N/A | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue